Atossa Competitors
| ATOS Stock | USD 1.50 0.01 0.67% |
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Atossa Genetics competition on your existing holdings.
Atossa |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Atossa Genetics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Atossa Genetics Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Atossa Genetics and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Atossa and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Atossa Genetics does not affect the price movement of the other competitor.
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Atossa Stock performing well and Atossa Genetics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Atossa Genetics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| NVAX | 3.68 | (0.09) | 0.02 | 0.06 | 5.32 | 9.11 | 49.36 | |||
| VXRT | 3.53 | 0.03 | 0.01 | 0.11 | 3.99 | 7.41 | 32.91 | |||
| INO | 5.10 | 0.37 | 0.09 | 0.23 | 5.55 | 12.74 | 30.56 | |||
| ENVB | 6.40 | 0.07 | 0.03 | 0.12 | 5.48 | 15.29 | 86.10 | |||
| CWBR | 4.16 | (1.73) | 0.00 | (11.34) | 0.00 | 6.67 | 60.37 | |||
| TNXP | 4.46 | (0.70) | 0.00 | (0.27) | 0.00 | 10.71 | 54.55 | |||
| SONN | 3.75 | 0.49 | 0.09 | 0.54 | 4.67 | 11.88 | 30.46 | |||
| ONTX | 20.84 | 9.34 | 2.99 | 0.54 | 0.96 | 8.70 | 19.83 | |||
| PALI | 6.48 | 0.02 | 0.03 | 0.09 | 9.01 | 11.30 | 119.62 | |||
| IBIO | 7.10 | 1.51 | 0.32 | 0.24 | 4.84 | 6.74 | 209.66 |
Cross Equities Net Income Analysis
Compare Atossa Genetics and related stocks such as Novavax, Vaxart Inc, and Inovio Pharmaceuticals Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NVAX | (5.5 M) | (19.4 M) | (28.5 M) | (52 M) | (82.9 M) | (156.9 M) | (280 M) | (183.8 M) | (184.7 M) | (130.1 M) | (427.5 M) | (1.7 B) | (657.9 M) | (545.1 M) | (517.8 M) |
| VXRT | 1000 K | (4.5 M) | (8.7 M) | (8.9 M) | (11 M) | (19.1 M) | (25.4 M) | (29.4 M) | (18 M) | (18.6 M) | (32.2 M) | (70.5 M) | (107.8 M) | (82.5 M) | (78.3 M) |
| INO | (6.6 M) | (15.3 M) | (19.7 M) | (66 M) | (36.1 M) | (29.2 M) | (73.7 M) | (88.2 M) | (97 M) | (120.6 M) | (215.1 M) | (305.4 M) | (287.7 M) | (135.1 M) | (128.4 M) |
| ENVB | (1.2 M) | (33.4 K) | (24.6 K) | (161) | (33.6 K) | (1.9 M) | (2.8 M) | (9.1 M) | (16.9 M) | (5.6 M) | (6.4 M) | (49 M) | (18.5 M) | (17.3 M) | (16.4 M) |
| TNXP | (21.1 K) | (3.5 M) | (9.4 M) | (10.9 M) | (27.6 M) | (48.1 M) | (38.8 M) | (21.1 M) | (26.1 M) | (28.4 M) | (50.4 M) | (92.2 M) | (115 M) | (116.7 M) | (110.8 M) |
| SONN | (1 M) | (1 M) | (1 M) | (6 M) | (6.4 M) | (12.1 M) | (9.1 M) | (6.8 M) | (6.9 M) | (5 M) | (31.1 M) | (25 M) | (29.8 M) | (18.8 M) | (19.8 M) |
| PALI | (3.1 M) | (12.5 M) | (10.1 M) | (19.8 M) | (22.6 M) | (20.9 M) | (21.1 M) | (15.7 M) | (4.9 M) | (8.4 M) | (10.6 M) | (27.3 M) | (12.8 M) | (12.3 M) | (12.9 M) |
| IBIO | (1.7 M) | (5.7 M) | (6.2 M) | (3.7 M) | (6.6 M) | (9.8 M) | (14.5 M) | (16.1 M) | (17.6 M) | (18.9 M) | (23.3 M) | (51 M) | (29.3 M) | (26.4 M) | (25.1 M) |
| JAGX | (25.5 M) | (8.6 M) | (8.6 M) | (8.6 M) | (8.6 M) | (16.3 M) | (14.7 M) | (22 M) | (32.1 M) | (38.5 M) | (36.8 M) | (60.3 M) | (47.5 M) | (41.3 M) | (43.4 M) |
| GOVX | 36.7 M | (2.3 M) | (2.1 M) | (2.3 M) | (2.7 M) | (2.7 M) | (3.3 M) | (2.2 M) | (2.6 M) | (2.4 M) | (2.9 M) | (18.5 M) | (14 M) | (26 M) | (24.7 M) |
| OCGN | (16.9 M) | (16.9 M) | (16.9 M) | (25.7 M) | (22.8 M) | (32 M) | (16.2 M) | (26.4 M) | (8.6 M) | (21.2 M) | (22.6 M) | (58.4 M) | (77.8 M) | (63.1 M) | (59.9 M) |
| AVRO | (4.7 M) | (4.7 M) | (4.7 M) | (4.7 M) | (4.7 M) | (4.7 M) | (4.7 M) | (18.6 M) | (46.4 M) | (72.1 M) | (118.5 M) | (117.7 M) | (106 M) | 12.2 M | 12.8 M |
| OCEA | (232 K) | (232 K) | (232 K) | (232 K) | (232 K) | (232 K) | (232 K) | (232 K) | (232 K) | (232 K) | (1.7 M) | (62.3 M) | 565.5 K | 508.9 K | 534.4 K |
| ELEV | (5.9 M) | (5.9 M) | (5.9 M) | (5.9 M) | (5.9 M) | (5.9 M) | (5.9 M) | (5.9 M) | (5.9 M) | (5.9 M) | (17.3 M) | (32 M) | (95.1 M) | (45.7 M) | (48 M) |
Atossa Genetics and related stocks such as Novavax, Vaxart Inc, and Inovio Pharmaceuticals Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Atossa Genetics financial statement analysis. It represents the amount of money remaining after all of Atossa Genetics operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Atossa Genetics Competitive Analysis
The better you understand Atossa Genetics competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Atossa Genetics' competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Atossa Genetics' competition over several years is one of the best ways to analyze its investment potential.| Better Than Average | Worse Than Peers | View Performance Chart |
Atossa Genetics Competition Performance Charts
Five steps to successful analysis of Atossa Genetics Competition
Atossa Genetics' competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Atossa Genetics in relation to its competition. Atossa Genetics' competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of Atossa Genetics in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Atossa Genetics' competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Atossa Genetics, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your Atossa Genetics position
In addition to having Atossa Genetics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Junk Bonds Funds Thematic Idea Now
Junk Bonds Funds
Funds or Etfs that invest most of their assets into speculative (junk) bonds or to other fixed income instruments with interest rates 3 to 4 percentage points above government issues. The Junk Bonds Funds theme has 42 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Junk Bonds Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Atossa Genetics Correlation with its peers. For more information on how to buy Atossa Stock please use our How to Invest in Atossa Genetics guide.You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Complementary Tools for Atossa Stock analysis
When running Atossa Genetics' price analysis, check to measure Atossa Genetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atossa Genetics is operating at the current time. Most of Atossa Genetics' value examination focuses on studying past and present price action to predict the probability of Atossa Genetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atossa Genetics' price. Additionally, you may evaluate how the addition of Atossa Genetics to your portfolios can decrease your overall portfolio volatility.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Stocks Directory Find actively traded stocks across global markets | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |
Is Atossa Genetics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Atossa Genetics. If investors know Atossa will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Atossa Genetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.24) | Return On Assets (0.18) | Return On Equity (0.29) |
The market value of Atossa Genetics is measured differently than its book value, which is the value of Atossa that is recorded on the company's balance sheet. Investors also form their own opinion of Atossa Genetics' value that differs from its market value or its book value, called intrinsic value, which is Atossa Genetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Atossa Genetics' market value can be influenced by many factors that don't directly affect Atossa Genetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Atossa Genetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Atossa Genetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Atossa Genetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.